• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

SIPC Share Price Performance

ج.م3.10
2.00 (181.82%)
ج.م3.10
2.00 (181.82%)
Price ج.م3.10

SIPC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
1 Reward

Sabaa International Company for Pharmaceutical and Chemical Industry Key Details

ج.م54.1m

Revenue

ج.م28.7m

Cost of Revenue

ج.م25.3m

Gross Profit

ج.م11.5m

Other Expenses

ج.م13.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.055
46.87%
25.58%
22.5%
View Full Analysis

About SIPC

Founded
2000
Employees
n/a
CEO
Sahal Morsi Al-Damrawi
WebsiteView website
www.sabaapharmagroup.com

Sabaa International Company for Pharmaceutical and Chemical Industry operates as a healthcare company in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets comprising Claudol and Flamogen E.C.T. The company also offers generics, OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

Recent SIPC News & Updates

Recent updates

No updates

Sabaa International Company for Pharmaceutical and Chemical Industry Competitors